Veterinary Medicines

Scanoporc EC/LT/CP -inaktywowane bakterie Escherichia coli serotyp O138:F18: nie mniej niż 10^9;-inaktywowane bakterie Escherichia coli serotyp O8:K88: nie mniej niż 10^9;-inaktywowane bakterie Escherichia coli serotyp O9:987P: nie mniej niż 10^9;-inaktywowane bakterie Escherichia coli serotyp O101:K99,F41: nie mniej niż 10^9;- toksoid LT E.coli: nie mniej niż 5 mg;-inaktywowane bakterie Clostridium perfringens typ C, ATCC 3628: nie mniej niż 7,5x10^8;-B-toksoid Cl. perfringens typ C, ATCC 3628: nie mniej niż 10 j.m. Zawiesina do wstrzykiwań

Not authorised
  • Escherichia coli, serotype O9 (fimbrial adehsin F6), Inactivated
  • Escherichia coli, serotype O8:K88, Inactivated
  • Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotype O138 (fimbrial adhesin F18), Inactivated
  • Escherichia coli, LT toxoid
  • Clostridium perfringens, type C, strain ATCC 3628, Inactivated
  • Clostridium perfringens, type C, strain ATCC 3628, alpha toxoid
Download as PDF

Product identification

Medicine name:
Scanoporc EC/LT/CP -inaktywowane bakterie Escherichia coli serotyp O138:F18: nie mniej niż 10^9;-inaktywowane bakterie Escherichia coli serotyp O8:K88: nie mniej niż 10^9;-inaktywowane bakterie Escherichia coli serotyp O9:987P: nie mniej niż 10^9;-inaktywowane bakterie Escherichia coli serotyp O101:K99,F41: nie mniej niż 10^9;- toksoid LT E.coli: nie mniej niż 5 mg;-inaktywowane bakterie Clostridium perfringens typ C, ATCC 3628: nie mniej niż 7,5x10^8;-B-toksoid Cl. perfringens typ C, ATCC 3628: nie mniej niż 10 j.m. Zawiesina do wstrzykiwań
Active substance:
  • Escherichia coli, serotype O9 (fimbrial adehsin F6), Inactivated
  • Escherichia coli, serotype O8:K88, Inactivated
  • Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotype O138 (fimbrial adhesin F18), Inactivated
  • Escherichia coli, LT toxoid
  • Clostridium perfringens, type C, strain ATCC 3628, Inactivated
  • Clostridium perfringens, type C, strain ATCC 3628, alpha toxoid
Target species:
  • Pig
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Escherichia coli, serotype O9 (fimbrial adehsin F6), Inactivated
    1000.00
    million organisms
    /
    1.00
    millilitre(s)
  • Escherichia coli, serotype O8:K88, Inactivated
    1000.00
    million organisms
    /
    1.00
    millilitre(s)
  • Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
    1000.00
    million organisms
    /
    1.00
    millilitre(s)
  • Escherichia coli, serotype O138 (fimbrial adhesin F18), Inactivated
    1000.00
    million organisms
    /
    1.00
    millilitre(s)
  • Escherichia coli, LT toxoid
    5.00
    milligram(s)
    /
    1.00
    milligram(s)
  • Clostridium perfringens, type C, strain ATCC 3628, Inactivated
    750.00
    million organisms
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type C, strain ATCC 3628, alpha toxoid
    10.00
    international unit(s)
    /
    1.00
    international unit(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Pig
      • All relevant tissues
        0
        day
  • Intramuscular use
    • Pig
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB08
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Scanvet Poland Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Ovejero S.A.U.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1780
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 15/11/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 15/11/2024
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 15/11/2024
Download